24-Hour Lung Function Following The Novel Lama/laba Co-Suspension Technology Of Glycopyrrolate/formoterol Fixed-Dose Combination Mdi, In Patients With Moderate-To-Very-Severe COPD

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE(2016)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要